Clinical studies
| GRI Standard and disclosure | Reference | Omission reason and Comment | ||||
|
3-3 |
Management of material topics |
|||||
Animal welfare
| GRI Standard and disclosure | Reference | Omission reason and Comment | ||||
|
3-3 |
Management of material topics |
|||||
Bioethics
| GRI Standard and disclosure | Reference | Omission reason and Comment | ||||
|
3-3 |
Management of material topics |
|||||
Digital ethics
| GRI Standard and disclosure | Reference | Omission reason and Comment | ||||
|
3-3 |
Management of material topics |
|||||
Access to health
| GRI Standard and disclosure | Reference | Omission reason and Comment | ||||
|
3-3 |
Management of material topics |
|||||
Prices of medicines
| GRI Standard and disclosure | Reference | Omission reason and Comment | ||||
|
3-3 |
Management of material topics |
|||||
Product-related crime
| GRI Standard and disclosure | Reference | Omission reason and Comment | ||||
|
3-3 |
Management of material topics |
|||||